| Weng, Jianping |
NCT06687733: Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects |
|
|
| Recruiting | 1/2 | 18 | RoW | NGGT002 | NGGT (Suzhou) Biotechnology Co., Ltd. | Phenylketonurias | 07/26 | 07/31 | | |
NCT03522870: Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus |
|
|
| Completed | N/A | 104 | RoW | Flash glucose monitoring system, Freestyle Libre®;Abbott Diabetes Care,Witney, Oxon,UK, SMBG, Capillary blood glucose tested by Bayer | Sun Yat-sen University | Diabetes Mellitus, Type 1 | 06/22 | 06/22 | | |
| Gao, Zhi-liang |
NCT04035837: The Clinical Cure Project of Chronic Hepatitis B in China |
|
|
| Recruiting | 4 | 30000 | RoW | pegylated interferon-alfa | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 06/23 | 06/24 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
| Liang, Lin B |
NCT05896124: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) |
|
|
| Recruiting | 2 | 75 | RoW | 2mg CS0159, Placebo | Cascade Pharmaceuticals, Inc | Primary Biliary Cholangitis (PBC) | 10/24 | 10/24 | | |
| Recruiting | 1 | 124 | RoW | Rifaximin 200 mg, Standard Treatment without Rifaximin | Sun Yat-sen University | Liver Failure, Acute on Chronic, Hepatic Encephalopathy, HBV, Hepatitis B, Rifaximin, Effect of Drug | 07/25 | 10/25 | | |
| Deng, Hong |
NCT03784222: Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients |
|
|
| Terminated | 4 | 102 | RoW | Blonanserin, MRI and serum BDNF | Sumitomo Pharma (Suzhou) Co., Ltd. | First Episode Schizophrenia, Social Function, Cognition Function, Blonanserin | 11/22 | 11/22 | | |
NCT06123858: Non-alcoholic Steatohepatitis Registry Platform Study |
|
|
| Recruiting | N/A | 2500 | RoW | | AstraZeneca | NASH With Fibrosis | 12/26 | 12/26 | | |
| Chen, Yuming |
NCT05074836: Milk Supplementation and Bone Health in Children |
|
|
| Enrolling by invitation | N/A | 254 | RoW | Formula milk, Regular milk, Control foods | Sun Yat-sen University, LanZhou University | Bone Density Increased, Body Height | 10/22 | 12/22 | | |
| Active, not recruiting | N/A | 5118 | NA | | Sun Yat-sen University | Cardiovascular Diseases, Osteoporosis, Diabetes Mellitus, Type 2, Metabolic Syndrome, Obesity, Hypertension, Non-Alcoholic Fatty Liver Disease, Chronic Kidney Diseases, Cancer, Death, Nutrition Disorders, Sarcopenia | 12/23 | 12/27 | | |
| Recruiting | N/A | 20000 | RoW | | Sun Yat-sen University, Shenzhen Nanshan Center for Chronic Disease Control | Hypertension, Type 2 Diabetes Mellitus, Cardiovascular Diseases, Stroke, Obesity, Metabolic Syndrome, Sarcopenia, Chronic Kidney Disease, Cancer, Death | 12/28 | 12/28 | | |
| Wei, Lai |
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C |
|
|
| Recruiting | 2/3 | 520 | RoW | HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo | Sunshine Lake Pharma Co., Ltd. | Chronic HCV Infection | 04/23 | 04/23 | | |
NCT05093855: Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) |
|
|
| Completed | 2 | 41 | RoW | BDB-001 Injection | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Hidradenitis Suppurativa | 08/23 | 08/23 | | |
NCT06168383: To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . |
|
|
| Recruiting | 2 | 180 | RoW | HSK31679 80mg, HSK31679 160mg, Placebo | Haisco Pharmaceutical Group Co., Ltd. | Non-Alcoholic Steatohepatitis (NASH) | 01/26 | 04/26 | | |
| Completed | 2 | 150 | US | QA102/Placebo, QA102, Placebo | Smilebiotek Zhuhai Limited | Dry Age-related Macular Degeneration | 11/24 | 11/24 | | |
NCT05103423: Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) |
|
|
| Completed | 1/2 | 50 | RoW | BDB-001 Injection, Placebo | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Hidradenitis Suppurativa | 07/23 | 07/23 | | |
NCT03108794: A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B |
|
|
| Recruiting | N/A | 200000 | RoW | | Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture，Xinjiang | Chronic Hepatitis B | 12/22 | 12/25 | | |
NCT06802731: LivQ-box® Parameters in the Diagnosis of Liver Inflammation |
|
|
| Recruiting | N/A | 365 | RoW | | Wuxi Hisky Medical Technology Co Ltd, Beijing Tsinghua Changgeng Hospital | Liver Inflammation, Fatty Liver Disease | 03/25 | 06/25 | | |
NCT06123858: Non-alcoholic Steatohepatitis Registry Platform Study |
|
|
| Recruiting | N/A | 2500 | RoW | | AstraZeneca | NASH With Fibrosis | 12/26 | 12/26 | | |
NCT05421572: Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) |
|
|
| Recruiting | N/A | 2000 | RoW | Fibrotouch | Beijing Tsinghua Chang Gung Hospital | Fatty Liver Disease | 12/22 | 12/22 | | |
NCT05451082: Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China |
|
|
| Not yet recruiting | N/A | 1000 | RoW | | Lai Wei | Hepatitis D | 06/28 | 12/28 | | |
| Gao, Zhiliang |
NCT05753280: Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB |
|
|
| Completed | 4 | 90 | RoW | Vitamin D | Third Affiliated Hospital, Sun Yat-Sen University | Chronic Hepatitis b | 06/22 | 06/22 | | |
NCT04035837: The Clinical Cure Project of Chronic Hepatitis B in China |
|
|
| Recruiting | 4 | 30000 | RoW | pegylated interferon-alfa | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 06/23 | 06/24 | | |
NCT04201808: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides |
|
|
| Recruiting | 4 | 100 | RoW | Tenofovir Alafenamide 25 MG, Vemlidy | New Discovery LLC, Beijing Ditan Hospital | Hepatitis B, Chronic | 09/23 | 09/23 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
NCT05937178: Real-world Study Optimizing Nucleotide-analogues |
|
|
| Recruiting | N/A | 20000 | RoW | ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF | Huashan Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, Beijing YouAn Hospital, Peking University People's Hospital, Peking University First Hospital, Xiamen Hospital of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, LanZhou University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, Tongji Hospital, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, the Second Hospital of Nangjing, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital of Nanchang University, Shengjing Hospital, Qingdao Sixth People's Hospital, Shandong Provincial Hospital Affiliated to Shandong First Medical University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, West China Hospital, Tianjin Second People's Hospital, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Yunnan, Shulan (Hangzhou) Hospital, Zhejiang University, Southwest Hospital, China, The Second Affiliated Hospital of Chongqing Medical University, Sichuan Provincial People's Hospital | Hepatitis B, Chronic | 01/29 | 01/29 | | |
| Yang, Yang |
NCT04486651: HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 560 | RoW | Irinotecan Hydrochloride Injection, HX008, Placebo | Taizhou Hanzhong biomedical co. LTD | Stomach Cancer | 08/23 | 08/23 | | |
| Terminated | 3 | 372 | Europe, US, RoW | Pamrevlumab, FG-3019, Placebo | FibroGen | Idiopathic Pulmonary Fibrosis | 09/23 | 09/23 | | |
|
NCT05043688: Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. |
|
|
| Recruiting | 3 | 426 | RoW | Camrelizumab, radiotherapy | Zhigang Li, Jiangsu HengRui Medicine Co., Ltd. | Resectable Esophageal Squamous Cell Carcinoma | 12/28 | 12/30 | | |
NCT05250843: TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC |
|
|
| Recruiting | 2/3 | 90 | RoW | TACE/HAIC, Lenvatinib, Sintilimab, liver resection | Third Affiliated Hospital, Sun Yat-Sen University | Hepatocellular Carcinoma | 12/23 | 12/24 | | |
NCT06272214: Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy |
|
|
| Recruiting | 2 | 146 | RoW | Adjuvant radiotherapy, Observation | Zhejiang Cancer Hospital | Adjuvant Radiotherapy | 03/27 | 03/29 | | |
NCT06413342: Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 191 | RoW | Sintilimab | Zhejiang Cancer Hospital | Esophageal Cancer, Chemoradiotherapy, Sintilimab, Immunotherapy, Elderly Patients | 06/26 | 06/28 | | |
IIT-2024-238, NCT06509568: Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial） |
|
|
| Recruiting | 2 | 92 | RoW | Neoadjuvant chemoradiotherapy followed by immunotherapy, Neoadjuvant chemoimmunotherapy | Zhejiang Cancer Hospital | Esophageal Squamous Cell Carcinoma | 08/25 | 08/26 | | |
NCT05738057: Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma |
|
|
| Recruiting | 2 | 22 | RoW | Camrelizumab, Gemcitabine Injection, Cisplatin injection, Cisplatin-Eluting Beads, D-TACE | Hua Li | Unresectable Intrahepatic Cholangiocarcinoma | 03/25 | 03/26 | | |
NCT05417321: A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 80 | US, RoW | HB0036, Anti-PD-L1 and anti-TIGIT bifunctional molecule | Shanghai Huaota Biopharmaceutical Co., Ltd. | Advanced Solid Tumor, NSCLC | 08/25 | 08/25 | | |
NCT05940610: The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure |
|
|
| Withdrawn | 1/2 | 20 | RoW | MSC-EVs | Third Affiliated Hospital, Sun Yat-Sen University | Acute-On-Chronic Liver Failure, Acute Liver Failure | 09/24 | 10/25 | | |
NCT05881668: MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation |
|
|
| Withdrawn | 1 | 30 | RoW | MSC-EV | Third Affiliated Hospital, Sun Yat-Sen University | Liver Failure, Acute on Chronic | 09/24 | 04/25 | | |
Neo-DRATEC, NCT03381651: Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma |
|
|
| Completed | N/A | 147 | RoW | Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation, Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation | Zhejiang Cancer Hospital | Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy, Surgery | 02/21 | 02/23 | | |
| Recruiting | N/A | 300 | US | T'ai Chi and Qigong Rehabilitation, Usual care | New York Presbyterian Hospital, Center for Taiji and Qigong Studies & Wa-Qi.com | Low Back Pain | 06/23 | 06/23 | | |
NCT04707053: Data Collection and Analysis in Brainstem Surgeries |
|
|
| Recruiting | N/A | 150 | Europe | | Cantonal Hospital of St. Gallen | Brainstem Lesion, Surgery, Intraoperative Neurophysiologic Monitoring | 12/23 | 12/25 | | |
| Recruiting | N/A | 1000 | RoW | internet plus model, control | Guizhou Provincial People's Hospital | Neonatal Jaundice | 10/24 | 05/25 | | |
UTTS, NCT06743477: A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme |
|
|
| Not yet recruiting | N/A | 5 | RoW | Supergraft | Hu Peng | Stem Cell Transplantation | 12/26 | 12/26 | | |
NCT05707520: Long-term Benefit of MPA in Liver Transplantation |
|
|
| Recruiting | N/A | 500 | RoW | enteric-coated mycophenolate (MPAs), None MPA | Third Affiliated Hospital, Sun Yat-Sen University, Shulan (Hangzhou) Hospital, RenJi Hospital, The First Affiliated Hospital of Zhengzhou University, Beijing YouAn Hospital, Huashan Hospital, The Third Xiangya Hospital of Central South University, West China Hospital, Hebei Medical University Third Hospital, People's Hospital of Guangxi, Beijing Friendship Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Liver Transplant Rejection, Immunosuppressant Adverse Reaction | 06/23 | 09/23 | | |
| Zheng, Hongting |
ESPTTN, NCT06423235: Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules |
|
|
| Not yet recruiting | 4 | 426 | RoW | regular dose of JiRui® Prunella oral liquid, 2x regular dose of JiRui® Prunella oral liquid, regular dose of placebo, 2x regular dose of placebo | Xintian Pharmaceutical | Thyroid Nodule | 07/25 | 07/28 | | |
NCT05238701: A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects |
|
|
| Completed | 1 | 104 | RoW | LPM3770164 sustained release tablet, LY03015, LPM3770164 sustained release tablet simulant, LY03015 simulant | Luye Pharma Group Ltd. | Huntington Disease, Tardive Dyskinesia | 11/23 | 11/23 | | |
NCT03522870: Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus |
|
|
| Completed | N/A | 104 | RoW | Flash glucose monitoring system, Freestyle Libre®;Abbott Diabetes Care,Witney, Oxon,UK, SMBG, Capillary blood glucose tested by Bayer | Sun Yat-sen University | Diabetes Mellitus, Type 1 | 06/22 | 06/22 | | |
| Rong, Limin |
NCT01997086: Percutaneous Transforaminal Endoscopic Discectomy vs Microendoscopic Discectomy for Treatment of Lumbar Disc Herniation |
|
|
| Active, not recruiting | 4 | 125 | RoW | Percutaneous transforaminal endoscopic discectomy (PTED), Microendoscopic discectomy (MED) | Third Affiliated Hospital, Sun Yat-Sen University | Lumbar Herniated Disc | 08/23 | 08/23 | | |
| Lai, Wei |
NCT06565884: Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles（F-MFR300-RD-003） |
|
|
| Completed | N/A | 224 | RoW | Home radiofrequency skin treatment instrument, Ultrasonic coupler for medical purposes | Flossom (GD) Beauty Technology Co., Ltd. | Skin Wrinkles | 09/23 | 09/23 | | |
YM-1, NCT06441799: Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles |
|
|
| Completed | N/A | 224 | RoW | Home radiofrequency skin treatment instrument, Ultrasonic coupler for medical purposes | Glomed(HN)Co.Ltd | Skin Wrinkles | 08/23 | 08/23 | | |
| Recruiting | N/A | 300 | RoW | Rocuronium priming dose | Taipei Medical University Hospital | Neuromuscular Blockade | 12/24 | 12/24 | | |
| Li, Hua |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
NCT05250843: TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC |
|
|
| Recruiting | 2/3 | 90 | RoW | TACE/HAIC, Lenvatinib, Sintilimab, liver resection | Third Affiliated Hospital, Sun Yat-Sen University | Hepatocellular Carcinoma | 12/23 | 12/24 | | |
NCT05565573: Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients |
|
|
| Recruiting | 2/3 | 148 | RoW | Medroxyprogesterone Acetate 500 MG Oral Tablet, MPA, Levonorgestrel-Releasing Intrauterine System, LNG-IUS, 52-mg LNG-IUS，Mirena | Hua Li | Fertility Sparing | 07/24 | 11/25 | | |
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. |
|
|
| Recruiting | 2/3 | 216 | RoW | B007, Cyclosporin Capsules | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Primary Membranous Nephropathy | 12/26 | 12/26 | | |
NCT04492787: Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) |
|
|
| Completed | 2 | 240 | NA | Changkang Granule, Changkang Placebo Granule | Tasly Pharmaceutical Group Co., Ltd | Irritable Bowel Syndrome with Diarrhea | 04/22 | 04/22 | | |
NCT04839926: A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects |
|
|
| Recruiting | 1 | 60 | RoW | 0.5mg CY150112, placebo, 1.5mg CY150112, 4.5mg CY150112, 10mg CY150112, 18mg CY150112, 24mg CY150112 | Jiangsu Nhwa Pharmaceutical Co., Ltd. | Schizophrenia | 08/21 | 08/21 | | |
TQB2618-AK105-Ib-04, NCT05975645: A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). |
|
|
| Recruiting | 1 | 40 | RoW | Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Hepatocellular Carcinoma | 12/24 | 04/25 | | |
NCT03936504: Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model |
|
|
| Recruiting | N/A | 100 | RoW | Control Group ：conventional exercise rehabilitation programs (CERP), Experimental Group ：Tai Chi cardiac rehabilitation program (TCCRP) | Chinese PLA General Hospital, Beijing Normal University | Coronary Heart Disease, Chronic Coronary Syndrome | 07/21 | 10/21 | | |
NCT06232213: Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model |
|
|
| Recruiting | N/A | 40 | RoW | | Hua Li | Personalized Cancer Treatment | 09/26 | 09/26 | | |
| Completed | N/A | 52 | US | Halcyon 4.0 system | Washington University School of Medicine, Varian Medical Systems | Brain Cancer, Head and Neck Cancer, Lung Cancer, Gastric Cancer, Ovarian Cancer, Colon Cancer | 10/24 | 10/24 | | |
SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis |
|
|
| Recruiting | N/A | 328 | RoW | Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon | DK Medical Technology (Suzhou) Co., Ltd. | Arteriovenous Fistula Stenosis | 07/27 | 07/27 | | |
AIM, NCT05032053: Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds |
|
|
| Recruiting | N/A | 3000 | RoW | Antithrombotic drugs | Xijing Hospital, Ankang Central Hospital, Yan'an University Affiliated Hospital | Ischemic Stroke | 12/25 | 10/26 | | |
| Recruiting | N/A | 60 | US | Tumor collection via biopsy, Blood collection, Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI), DBSI MRI | Washington University School of Medicine, National Cancer Institute (NCI) | Locally Advanced Cervical Carcinoma, Locally Advanced Cervical Cancer, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Cancer, Cervical Cancer, Pancreas Cancer, Pancreatic Cancer, Cancer of the Cervix, Cancer of the Pancreas | 12/32 | 12/32 | | |
| Zhu, Xiang |
| Recruiting | N/A | 500 | RoW | | Tongji Hospital | HFRS | 12/23 | 12/23 | | |
| liu, fang |
NCT05643651: Rivaroxaban for Children With Giant Coronary Artery Aneurysms After Kawasaki Disease |
|
|
| Not yet recruiting | 4 | 100 | RoW | Rivaroxaban Oral Tablet [Xarelto], Xarelto, Aspirin or Clopidogrel, Antiplatelet therapy, Warfarin, Vitamin K Antagonist | Children's Hospital of Fudan University | Kawasaki Disease, Coronary Artery Aneurysm | 06/27 | 09/27 | | |
NCT04078568: Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease |
|
|
| Active, not recruiting | 3 | 3208 | RoW | IVIG, Intravenous Immunoglobulins, Human, Aspirin, Acetylsalicylic acid, Prednisolone, STEROLONE | Children's Hospital of Fudan University, Jiangxi Province Children's Hospital, First People's Hospital of Hangzhou, Shengjing Hospital, The First Hospital of Jilin University, Chengdu Women's and Children's Central Hospital, Children's Hospital of Chongqing Medical University, Inner Mongolia People's Hospital, Sichuan Provincial People's Hospital, Wuhan Union Hospital, China, Third Affiliated Hospital of Zhengzhou University, Children's Hospital of Soochow University, Yuying Children's Hospital of Wenzhou Medical University, Beijing Children's Hospital, Qilu Hospital of Shandong University | Kawasaki Disease | 12/24 | 12/25 | | |
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 552 | RoW | ICP-332 Tablets, ICP-332 Placebo Tablets | Beijing InnoCare Pharma Tech Co., Ltd. | Atopic Dermatitis | 11/26 | 12/26 | | |
NCT06020066: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI |
|
|
| Recruiting | 2 | 202 | RoW | EGFR-TK Inhibitor, Stereotactic radiotherapy | Fudan University | Brain Metastases, Non-small Cell Lung Cancer | 08/28 | 08/29 | | |
NCT04162353: BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma |
|
|
| Recruiting | 1 | 12 | RoW | BCMA-CD19 cCAR T cells | iCell Gene Therapeutics, iCAR Bio Therapeutics Ltd., Peking University Shenzhen Hospital | Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Plasmacytoid; Lymphoma | 09/21 | 09/21 | | |
NCT04162340: CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies |
|
|
| Recruiting | 1 | 12 | RoW | CD4 CAR T cells | iCell Gene Therapeutics, iCAR Bio Therapeutics Ltd., Peking University Shenzhen Hospital | T Cell Lymphoma in Relapse, Refractory T-Cell Lymphoma | 10/21 | 10/21 | | |
NCT03795779: CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies |
|
|
| Recruiting | 1 | 20 | RoW | CLL1-CD33 cCAR T cells | iCell Gene Therapeutics, The General Hospital of Western Theater Command, iCAR Bio Therapeutics Ltd., Peking University Shenzhen Hospital | Hematologic Malignancy, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Chronic Myeloid Leukemia | 09/22 | 09/22 | | |
NCT03522870: Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus |
|
|
| Completed | N/A | 104 | RoW | Flash glucose monitoring system, Freestyle Libre®;Abbott Diabetes Care,Witney, Oxon,UK, SMBG, Capillary blood glucose tested by Bayer | Sun Yat-sen University | Diabetes Mellitus, Type 1 | 06/22 | 06/22 | | |
NCT05138731: Metabolomics Profiling of Coronary Heart Disease |
|
|
| Recruiting | N/A | 821 | RoW | treatments according guidelines | General Hospital of Ningxia Medical University | Biomarkers | 01/23 | 05/23 | | |
NCT03915795: Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities |
|
|
| Completed | N/A | 30 | RoW | | Children's Hospital of Fudan University | Kawasaki Disease, Coronary Artery Abnormalities | 01/23 | 12/23 | | |
NCT06267768: The Effects of Inspiratory Pressures on Diaphragmatic Contraction in People After Stroke |
|
|
| Completed | N/A | 36 | RoW | Various intensities of inspiratory muscle training | Hong Kong Metropolitan University, Shenzhen Second People's Hospital | Stroke | 08/24 | 08/24 | | |
SAPLIC, NCT06734481: Effectiveness and Safety of Sodium Bicarbonate Pleural Lavage in the Treatment of Complex Pleural Effusion |
|
|
| Recruiting | N/A | 260 | RoW | Sodium bicarbonate pleural lavage, Saline pleural lavage | First Affiliated Hospital of Ningbo University | Complicated Pleural Effusion/ Empyema | 05/26 | 08/26 | | |
NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA |
|
|
| Recruiting | N/A | 492 | RoW | | LI YAN | T2DM | 12/25 | 07/26 | | |
NCT06447272: Effects of IMT on Respiratory, Diaphragmatic and Balance Functions, Exercise Capacity and QOL in People After Stroke |
|
|
| Not yet recruiting | N/A | 76 | NA | sham inspiratory muscle training, target inspiratory muscle training | Hong Kong Metropolitan University | Stroke | 05/26 | 06/26 | | |
| Zhang, Qi |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT03750669: Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer |
|
|
| Active, not recruiting | 3 | 324 | RoW | AG regimen, Nab-paclitaxel and Gemcitabine, mFolfirinox, Folic acid, 5- fluorouracil, irinotecan and oxaliplatin | Second Affiliated Hospital, School of Medicine, Zhejiang University | Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemotherapy | 04/24 | 04/26 | | |
| Terminated | 2 | 3 | RoW | osimertinib mesylate tablets and anlotinib hydrochloride capsules, TAGRISSO and FOCUS V | First Affiliated Hospital of Zhejiang University | Non Small Cell Lung Cancer | 12/22 | 02/23 | | |
NCT03662412: Study of Sirolimus in Patients With Advanced Pancreatic Cancer |
|
|
| Recruiting | 2 | 36 | RoW | Sirolimus, Rapamycin | Second Affiliated Hospital, School of Medicine, Zhejiang University | Pancreatic Cancer | 06/23 | 06/23 | | |
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) |
|
|
| Recruiting | 2 | 140 | RoW | UC-MSCs, Placebo(solution without UC-MSCs) | Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital | Decompensated Cirrhosis | 06/25 | 06/27 | | |
NCT03633773: Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma |
|
|
| Recruiting | 1/2 | 9 | RoW | MUC-1 CART cell immunotherapy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Intrahepatic Cholangiocarcinoma | 08/23 | 12/24 | | |
NCT03633747: Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma |
|
|
| Recruiting | 1/2 | 25 | RoW | Propranolol Hydrochloride | Second Affiliated Hospital, School of Medicine, Zhejiang University | Hemangioma Liver | 08/23 | 12/24 | | |
NCT03633734: Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma |
|
|
| Recruiting | 1/2 | 49 | RoW | Sequential Treatment, Sequential Treatment With AG and Modified Folfirinox | Second Affiliated Hospital, School of Medicine, Zhejiang University | Pancreatic Adenocarcinoma Metastatic, Chemotherapy Effect | 08/23 | 12/24 | | |
NCT04533724: Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia |
|
|
| Not yet recruiting | 1 | 6 | NA | Amisulpride | Shanghai Mental Health Center | Negative Symptom, Schizophrenia, Amisulpride, Gut Microbiomes | 09/22 | 09/22 | | |
NCT06461624: Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma |
|
|
| Recruiting | 1 | 15 | RoW | anti-GPC3 CAR-T, CBG166 CAR-T | Zhejiang University, Carbiogene Therapeutics Co. Ltd. | Advanced Hepatocellular Carcinoma | 07/27 | 10/27 | | |
NCT06026605: A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors |
|
|
| Recruiting | 1 | 44 | RoW | WTX212A | Zhejiang University | Unresectable or Metastatic Advanced Solid Tumors | 08/26 | 08/26 | | |
| Recruiting | N/A | 200 | RoW | coronary revascularization | Shanghai East Hospital | Multivessel Coronary Artery Disease | 12/21 | 12/23 | | |
| Not yet recruiting | N/A | 220 | RoW | Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR), Paclitaxel-Eluting Balloon (Bingo) | CCRF Inc., Beijing, China | Percutaneous Coronary Intervention | 05/22 | 10/22 | | |
ASORPWICE, NCT03521739: Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events |
|
|
| Recruiting | N/A | 100000 | RoW | | Chinese Academy of Medical Sciences, Fuwai Hospital | Blood Pressure, Pulse Wave Analysis, Ankle Brachial Index, Patient Outcome Assessment | 12/22 | 12/23 | | |
| Recruiting | N/A | 30 | Europe, US, RoW | | Sunnaas Rehabilitation Hospital, Oslo Metropolitan University, University of Oslo, Karolinska Institutet | Pediatric ALL, Spinal Cord Injuries | 12/22 | 12/24 | | |
NCT05475756: Safety and Efficacy of Intrauterine Biological Barrier on Postoperative Adhesion After Hysteroscopic Adhesiolysis |
|
|
| Recruiting | N/A | 264 | RoW | Intrauterine Biological Barrier, Intrauterine Adhesion Barrier Gel | Beijing Tiantan Hospital, Zhangzhou Municipal Hospital of Fujian Province, Guangzhou First People's Hospital, Tang-Du Hospital, Suzhou Municipal Hospital, Anhui Provincial Hospital | Intrauterine Adhesion | 05/24 | 05/25 | | |
NCT05866029: Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture |
|
|
| Recruiting | N/A | 2478 | RoW | Denosumab, Teriparatide | Peking Union Medical College Hospital | Osteoporotic Fractures | 09/26 | 09/26 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
NCT05433935: Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
|
|
| Recruiting | N/A | 5000 | RoW | Observation | Zhejiang University, The Second Hospital of Hebei Medical University, Second Affiliated Hospital of Nanchang University, Meng Chao Hepatobiliary Hospital of Fujian Medical University, Huizhou Municipal Central Hospital, Shengzhou People's Hospital | Intraductal Papillary Mucinous Neoplasm | 06/32 | 12/33 | | |
| Peng, Liang |
NCT05382013: Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment |
|
|
| Recruiting | 4 | 60 | RoW | Avatrombopag, Artificial Liver Support System, Comprehensive internal medical treatment. | Third Affiliated Hospital, Sun Yat-Sen University | Thrombocytopenia, Hepatitis B, Chronic, Acute-On-Chronic Liver Failure | 02/24 | 04/24 | | |
NCT04640129: HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir. |
|
|
| Recruiting | 4 | 336 | RoW | PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate | Third Affiliated Hospital, Sun Yat-Sen University | Liver Fibrosis | 11/25 | 11/25 | | |
